About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
IP: Judit Cabana Dominguez Collaborators: Genetic and molecular mechanisms of neuropsychiatric disorders Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 236350 Reference: RYC2021-031324-I Duration: 01/03/2023 - 01/12/2027
IP: Maria Soler Artigas Collaborators: Towards precision medicine in comorbid disorders: a a genetic approach Funding agency: Instituto de Salud Carlos III Funding: 308600 Reference: CP22/00128 Duration: 01/01/2023 - 31/12/2027
IP: Silvia Alemany Sierra Collaborators: Genetic and environmental underpinnings of individual differences in psychiatric and neurodevelopmental disorders Funding agency: Instituto de Salud Carlos III Funding: 308600 Reference: CP22/00026 Duration: 01/01/2023 - 31/12/2027
IP: Jorge Serra Pueyo Collaborators: Anna Beneria González, Claudia Barber Caselles, Luis Gerardo Alcala Gonzalez Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI22/00618 Duration: 01/01/2023 - 31/12/2026
Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.
A project led by the Vall d’Hebron Research Institute (VHIR) in collaboration with FIDMAG Germanes Hospitalàries Research Foundation describes structural and functional brain changes in adolescents with borderline personality disorder (BPD).
A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes
